Oculis (OCS) stock jumps as the FDA grants Breakthrough Therapy designation for its eye disease drug Privosegtor targeted at ...

BENGALURU: Across Bengaluru and several other cities, ophthalmologists reported that there is a steady rise in diabetic ...

Learn about the Dental-Skeletal-Retinal Anomaly, a genetic disorder that affects the Cane Corso breed, and understand its ...

Nandita Vijayasimha, Bengaluru Friday, January 2, 2026, 09:00 Hrs [IST] ...

SpliceBio, a clinical-stage genetic medicines company pioneering protein splicing to address diseases caused by mutations in large genes, today announced the appointment of Don Munoz as Chief Financia ...

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

Ocugen (OCGN) rated Buy as OCU410ST Stargardt trial advances; FDA/EMA alignment speeds path to approval. Read here for more ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger ...

Dr Owen Jones, recipient of the 2024 ISSCR Travel Grant supported by Amsbio, reflects on his work developing human stem ...

A groundbreaking study reveals a surprising link between eye health and dementia risk. Researchers found that a thinner ...

Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing in the registrational PIONEER program across 2 key ...

Here is a look at the top economic stories in the Huntsville area in 2025: Eli Lilly’s Dec. 9 announcement that it was ...